• Tue. Dec 1st, 2020

MyoKardia: Phase 3 EXPLORER-HCM Clinical Trial Results Of Mavacamten For Obstructive Hypertrophic Cardiomyopathy

Myokardia

MyoKardia Presents Results from Phase 3 EXPLORER-HCM Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy. Press release sent to Zennie62Media, which reads..

EXPLORER-HCM Data Presented During Live Hot Line Session at ESC Congress 2020 with Simultaneous Publication in The Lancet

Presentation Expands on Positive Topline Results Showing Early, Sustained Reductions in Biomarkers of Cardiac Wall Stress and Myocardial Injury

Mavacamten Demonstrated Broad Treatment Effect, with Consistent Benefit Across Primary and Secondary Endpoints Among All Prespecified Patient Subgroups

MyoKardia to Host a Virtual Analyst and Investor Event to
Review Data on Monday, August 31 at 8:00 a.m. EDT

BRISBANE, Calif., Aug. 29, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) announced today that 30-week results from its pivotal Phase 3 EXPLORER-HCM clinical trial of mavacamten for the treatment of symptomatic, obstructive hypertrophic cardiomyopathy (HCM) were presented during a live Hot Line session at the European Society of Cardiology Congress 2020 (ESC Congress 2020). Results from the EXPLORER-HCM study were simultaneously published in The Lancet. MyoKardia previously announced topline data from the EXPLORER-HCM study showing that patients treated with mavacamten experienced statistically significant and clinically meaningful improvements in symptoms, functional status and key aspects of quality of life. In addition to meeting the primary and all secondary endpoints, mavacamten was well tolerated with a safety profile similar to placebo. The data presented today and reported in the published manuscript also include mavacamten’s positive impact on reducing cardiac biomarkers associated with poor prognosis and demonstrate the consistency of its therapeutic benefit across multiple prespecified subgroups.

“Hypertrophic cardiomyopathy can be a debilitating, chronic and progressive condition in patients, impairing the function of the heart and lowering patients’ quality of life. Mavacamten is the first therapeutic candidate to target the heart muscle proteins that drive the excessive contractility and impaired relaxation that are hallmarks of HCM with the intent of correcting the abnormal function of the heart. The results from EXPLORER provide clear, convincing evidence of the therapeutic effect of such a targeted mechanism of action; mavacamten was shown to alleviate the obstruction of the left ventricle and improve patients’ symptoms and cardiac function,” said Daniel Jacoby, M.D., Director, Comprehensive Heart Failure Program at the Yale School of Medicine, an investigator in the EXPLORER-HCM study.

The randomized, controlled, pivotal EXPLORER-HCM Phase 3 clinical trial enrolled 251 symptomatic, obstructive patients with HCM, most of whom were on standard background HCM therapy. Among the new data presented today, mavacamten treatment was shown to markedly reduce key biomarkers of cardiac wall stress and injury in a pronounced and clinically meaningful way. Serum concentrations of N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to Week 30 were reduced by 80%, to near normal levels, in the mavacamten treatment group relative to placebo. NT-proBNP is a well-established biomarker of cardiac wall stress that has been associated with increased mortality in HCM patients.(1,2) The decrease in NT-proBNP was observed at the earliest timepoint measured (Week 4) and was sustained throughout the 30-week treatment period. Similarly, reductions in cardiac troponin (hs-cTnI) from baseline to Week 30 were 41% greater in the mavacamten-treated cohort compared to placebo. Cardiac troponin I is closely associated with increased incidence of heart failure, atrial fibrillation and death in patients with HCM.(1,3)

“The early and durable reductions toward normal levels of well-established biomarkers associated with cardiac wall stress and injury provide us with early indications that mavacamten may be able to reduce risk of serious complications and poor outcomes,” said Jay Edelberg, M.D., Ph.D., Chief Medical Officer. “The reductions in biomarkers seen in the EXPLORER-HCM study are consistent with our observations of mavacamten’s impact on biomarkers across all of our studies of HCM as well as with the hemodynamic and structural benefits that we see taking place in the heart via cardiac imaging. We will be looking to our long-term studies for further evidence of the potential of mavacamten to alter the course of disease by returning the heart to a healthier state.”

As previously reported, mavacamten demonstrated a robust treatment effect in the Phase 3 study. The primary endpoint, a composite functional analysis designed to capture the treatment effect of mavacamten relative to placebo on both symptoms and cardiac function, was met with statistical significance (p=0.0005). Additionally, mavacamten demonstrated beneficial results (p<0.0006) for all secondary endpoints: post-exercise left ventricular outflow tract (LVOT) peak gradient, peak VO2, New York Heart Association (NYHA) functional classification, the Kansas City Cardiomyopathy Clinical Summary Score (KCCQ-CSS), and the HCM Symptom Questionnaire Shortness of Breath Domain Score. Data presented today and published in The Lancet reveal that mavacamten’s benefit versus placebo for the primary and all secondary endpoints extended across all prespecified subgroups. Specifically, the reduction in obstruction and the improvements in exercise capacity and clinician (NYHA) and patient (KCCQ and HCMSQ) assessments favoring mavacamten over placebo were highly consistent regardless of age, gender, genetic status, body mass index, background use of beta blockers, or baseline measures of ejection fraction, NYHA class and NT-proBNP. “The consistency of mavacamten’s effects in reducing obstruction and improving symptoms and quality of life across nearly a dozen pre-specified subgroups is a strong testament to the potential broad applicability of this therapy in obstructive HCM,” said Iacopo Olivotto, M.D., of the Cardiomyopathy Unit, Careggi University Hospital and lead clinical investigator for the EXPLORER-HCM clinical trial. “It has been extremely gratifying to directly witness the benefits derived from treatment with mavacamten among my patients who were on study, and I look forward to mavacamten becoming an integral tool in the treatment of patients with obstructive HCM in the future.” Mavacamten was well tolerated and demonstrated safety results similar to placebo, with no new findings observed from those previously reported. Ninety-seven percent of patients enrolled completed the study treatment period. Overall rates of adverse events, serious adverse events, and cardiac adverse events, including atrial fibrillation, were comparable for patients treated with mavacamten and placebo. Mavacamten was granted breakthrough therapy designation from the U.S. Food and Drug Administration in July 2020. MyoKardia plans to submit a New Drug Application for mavacamten to the U.S. Food and Drug Administration (FDA) in the first quarter of 2021.

Investor and Analyst Conference Call and Live Webcast

MyoKardia will host a virtual event for investors and analysts to review the 30-week data from EXPLORER-HCM. The live webcast event will begin at 8:00 a.m. EDT / 5:00 a.m. PDT on Monday, August 31 and will include a discussion of the EXPLORER data with Drs. Olivotto and Jacoby, as well as presentations from MyoKardia management regarding the impact of the positive data on MyoKardia and the company’s early commercial preparation efforts.

To access the call, please dial (844) 494-0193 (U.S.) or (508) 637-5584 (international) and reference the conference ID 9917969. A live webcast of the conference call will be available on Investor section of MyoKardia’s website at http://investors.myokardia.com. A replay of the webcast, and accompanying slides, will be available on the MyoKardia website for 90 days following the call.

About EXPLORER-HCM

The EXPLORER-HCM Phase 3 trial enrolled a total of 251 patients with symptomatic (NYHA Class II or III), obstructive hypertrophic cardiomyopathy. All participants had measurable LVOT gradient (resting and/or provoked) ≥50 mmHg at baseline. Patients were randomized on a 1:1 basis to receive individualized once-daily dosing of mavacamten or placebo. Patients started on a dose of 5mg, with up to two opportunities for dose adjustments (to doses of 2.5mg – 15mg) based on a combination of residual LVOT gradient, drug plasma concentration and left ventricular ejection fraction (LVEF) levels.

The primary endpoint for EXPLORER-HCM was a composite functional analysis designed to capture mavacamten’s effect on both symptoms and function. The composite functional endpoint is defined by either (1) the achievement of a ≥1.5mL/kg/min improvement in peak VO2 accompanied by an improvement of ≥1 NYHA functional class, or (2) the achievement of a ≥3.0mL/kg/min improvement of peak VO2 with no worsening in NYHA functional class. In addition to the endpoints reported today, the EXPLORER-HCM study also assessed mavacamten’s effect on patient-reported outcomes, health-related quality-of-life and symptom severity assessments, changes from baseline to Week 30 in echocardiographic indices, circulating biomarkers, cardiac rhythm patterns and accelerometry.

About HCM

Hypertrophic cardiomyopathy (HCM) is a chronic, progressive disease in which excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction. HCM is estimated to affect one in every 500 people. The most frequent cause of HCM is mutations in the heart muscle proteins of the sarcomere. In approximately two-thirds of HCM patients, the path followed by blood exiting the heart, known as the left ventricular outflow tract (LVOT), becomes obstructed by the enlarged and diseased muscle, restricting the flow of blood from the heart to the rest of the body (obstructive HCM). In other patients, the thickened heart muscle does not block the LVOT, and their disease is driven by diastolic impairment due to the enlarged and stiffened heart muscle (non-obstructive HCM). In either obstructive or non-obstructive HCM patients, exertion can result in fatigue or shortness of breath, interfering with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risks of atrial fibrillation, stroke, heart failure and sudden cardiac death.

About Mavacamten

MyoKardia is developing mavacamten, a first-in-class, oral, allosteric modulator of cardiac myosin, for the treatment of conditions in which excessive cardiac contractility and impaired diastolic filling of the heart are the underlying cause. Mavacamten is reduces cardiac muscle contractility by inhibiting excessive myosin-actin cross-bridge formation that results in hypercontractility, left ventricular hypertrophy and reduced compliance. In clinical and preclinical studies, mavacamten has consistently reduced biomarkers of cardiac wall stress, lessened excessive cardiac contractility and increased diastolic compliance.

Mavacamten is initially being developed for the treatment of hypertrophic cardiomyopathy (HCM) and has received breakthrough therapy and orphan drug designations for symptomatic, obstructive HCM. MyoKardia plans to submit a New Drug Application (NDA) for U.S. regulatory approval in this indication in the first quarter of 2021. Based on mavacamten’s mechanism of action and evidence of therapeutic activity, MyoKardia plans to study mavacamten for the treatment of symptomatic non-obstructive HCM and among a targeted population of patients with heart failure with preserved ejection fraction (HFpEF).

About MyoKardia

MyoKardia is a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases. The company is pioneering a precision medicine approach to its discovery and development efforts by 1) understanding the biomechanical underpinnings of disease; 2) targeting the proteins that modulate a given condition; 3) identifying patient populations with shared disease characteristics; and 4) applying learnings from research and clinical studies to inform and guide pipeline growth and product advancement. MyoKardia’s initial focus is on small molecule therapeutics aimed at the proteins of the heart that modulate cardiac muscle contraction to address diseases driven by excessive contraction, impaired relaxation, or insufficient contraction. Among its discoveries are three clinical-stage therapeutics: mavacamten (formerly MYK-461); danicamtiv (formerly MYK-491) and MYK-224.

MyoKardia’s mission is to change the world for people with serious cardiovascular disease through bold and innovative science.

Kubo, et al.; Circulation; 2011.
Geske, et al.; Journal of the American College of Cardiology; 2013.
Seydelmann et al.; Journal of the American Heart Association; 2016.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements, including statements regarding the clinical and therapeutic benefit and future potential of mavacamten, the ability of our long-term studies to provide further evidence of mavacamten’s potential to alter the course of disease by returning the heart to a healthier state, the impact of the FDA’s breakthrough therapy designation, or our plan and timing to submit a New Drug Application for mavacamten, reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation, risks associated with the development and regulation of our product candidates and any ongoing effects of the COVID-19 pandemic, as well as those set forth in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and our other filings with the SEC. Except as required by law, we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Avatar

Zennie Abraham

Zennie Abraham is Zennie62Media, Inc. CEO and Zenophon Abraham Zennie62 YouTube Channel vlogger, and creator of Oakland News Now and Zennie62Media's 100-blog network. He's covered the NFL, San Diego Comic Con, The Night of 100 Stars Oscars Party, The NFL Draft, and CES Las Vegas annually more than 10 years. He created Oakland's first true blog, Oakland Focus, and Oakland's first YouTube Partner Channel. Zennie also holds the distinction of forming Oakland's only bid to host the NFL's Super Bowl Game, in 2000 for the 2005 game that Jacksonville won the right to host. He's also the founder of Sports Business Simulations and the creator of The Oakland Baseball Simworld and XFL Simworld.

OaklandNewsNow.com, Oakland News Now, Oakland-News-Now.com @OaklandNewsNow oaklandnewsblog.com is by Zennie62Media, Inc. with CEO Zenophon Abraham AKA Zennie62 YouTube Zennie62.com Oakland News Now Commentary Vlog YouTube Partner, Oakland California blogger / vlogger Zennie Abraham @ZennieAbraham . Hire @Zennie62Media, Inc to tell your story. Zennie62Media uses smartphones enabling our 98-blog network, specially-made blogs, website, social media platforms covering politics, news, sports, and tech, streamyard, ZOOM, www.cnn.com, OAL Oakland Athletic League, @Oaklandcitynews, John Burris Law, police brutality cases, former Oakland Army Base site, Oakland Police federal monitor, housing for homeless people, Oakland CARES fund, Berkeley City Councilmember, Alameda City Councilmember, San Leandro City Councilmember, Oakland City Councilmember, Oakland City Council, North Oakland, East Oakland, Montclair, Adams Point, Uptown Oakland food culture, Oakland City, Oakland Cemetery, Oakland crime, Oakland directions, Oakland airport, Oakland, California ghetto, Oakland, California Map, Oakland Raiders, Oakland City Hall Plaza, East Oakland, Jack London Square, The Alley Cat Bar, Golden State Warriors, Chase Center, Bob Myers, Joe Lacob, Peter Guber, NBC Bay Area, Council-Member, Councilmember, Council President, Mayor of Oakland, Public-Safety, Affordable Housing, BBQ Becky Dr. Jennifer Schulte , Jogger Joe Henry Sintay, Oakland crime news, Chauncey Bailey, Bank of America loans, COVID-19 updates, homeless news, SF Bay Area news, Martuni's Piano Bar SF, Paul Hlebcar, Jackie Simpkins, Oakland artists, Jeff Loeb, @breakingnewsbayarea, Emeryville, Atlanta news, Chevron Ecuador, Steven Donziger, Fayetteville GA news, @FayettevilleGA Fayette County Georgia, San Francisco news, San Jose news. Also, David Rubin Academy Awards, The Oscars ceremony ,Tom Hanks, Skyline High School, Oakland Sports, Oakland Panthers, Oakland Coliseum, Honda of Oakland, Oakland Arena, Oakland Raiders, Las Vegas Raiders, Las Vegas Stadium Construction, Allegiant Stadium, Las Vegas Stadium Authority, NBA, NFL, NFL Draft, NFL Combine, CES Las Vegas tech, San Diego Comic Con sci-fi. @GrandLakeTheater @LasVegasHotels, Penny Dreadful City of Angels, Academy of Motion Picture Arts and Sciences, AMPAS Zennie62Media has content development and online reputation management clients like Insight Terminal Solutions @InsightTerminalSolutions and The Oakland Bulk and Oversized Terminal, with California Capital Investment Group Managing Partner Phillip Phil Tagami @PhilTagami co-developer, JMB Capital Partners, @JohnSiegel, John Siegel as ITS CEO exposing coal and Oakland fake news, Greg Minor oakland, Pat Cashman, Humanist Hall, David Oertel, lyft commercial kaplan, uber tax, lyft driver. Zennie62 has helped Maria Ayerdi Kaplan @MariaAyerdiKaplan, developer of Salesforce Transit Center in San Francisco, Kofi Bonner Five Points, San Francisco Shipyard, and Flowsent capture the Oakland Cannabis Delivery Dispensary @OaklandCannabis market with fitness model female bodybuilder Laura Ehlen and weedmaps help. We’ve partnered with CoLoursTV, CNN, 48Hills, TechCrunch, Quicken Loans, Bedrock Development, SFist, YouTube, Google, NBC, Vice, Oakland Post / Post News Group, Landis PR, and other media organizations. Competition: The SF Chronicle, San Francisco Chronicle, Streetsblog San Francisco, SFStreetsBlog.org, San Francisco Business Times, Bizjournals.com, NY Times, Salt Lake Tribune, LA Times, Los Angeles Times, Daily Californian, KQED, KALX, KPIX, KRON, KTVU, Las Vegas Review Journal, News-Democrat, East Bay Express, Oakland Tribune, Oakland Voices, The Mercury News, AJC, Atlanta Journal Constitution, Hoodline, SF Examiner, Sports Illustrated, Sanpete Messenger, The Citizen, The Athletic, The Montclarion, Marin Independent-Journal Zennie62 interviews celebrities like Cafe 817, Marin County Supervisor Damon Connolly, Lars Frykman, London, Faizon Love wife, David Squires, Aldon Smith NFL, Faizon Love, scott haggerty, Jay Glazer, Bill Boyd, Arizona Cardinals QB Kyler Murray, Garrett Gilbert Cowboys, Sarah Isgur Trump, Spin1038, Dak Prescott, Charles Woodson, Raiders Owner Mark Davis net worth, Raider Legend Raymond Chester, Brianna Noble, Vince Vaughn, Malin Akerman,Jon Favreau, Kristin Davis, Karen Bass, Willie Brown, Hala Hijazi, Jason Bateman, Jim Caldwell, Matt Patricia, Kristen Bell, Jean Reno, .NY Giants Owner John Mara, @SportsTalk Tony Bruno, Sports Agent Leigh Steinberg, net worth, Oakland City Charter, vloggers, Mason Riggs, Richard Haick, Fox News Tucker Carlson, Henry Sintay Oakland’s “Jogger Joe”, Alameda Labor Council, Cam Newton, Danny Vitale, Henry Ruggs, Cee Dee Lamb, Jerry Jeudy, Chris Cabott, sports academy, NFL Commissioner Roger Goodell, California Governor Gavin Newsom, Tanis Parenteau, Scott Kidd, Actors Richard Dreyfuss, Jim Kelly and John Saxon of Enter The Dragon, Lou Ferrigno, Lindsey Vonn hot legs, Blake Neely, SDCC’s David Glanzer, Publicist Edward Lozzi. Topics like Oakland Apartment rents, Essex Oakland, Fortress Investments, Forest City Development Housing, Lennar Corporation, Oakland City Center, 1200 Lakeshore, Perch Coffee, Haddon Hill, 565 Bellevue, Lake Chalet, Room 389, Golden Bear, Jerry Figone, Johnny Love Metheny, Lakeshore Business District, Eastmont Mall, WordPress, CVS Mail Order and Pharmacy, Kaiser Permanente, Rosa's Home Cooking Restaurant, Oakland Community Kitchens, Lukas Oakland, Maria Alderete, The Studio Cafe, Black Lives Matter, iron ore and coal, John Muir, Oakland hangman noose problem, Oakland NFL Football, Rayzin Schnitzer 11th Street Diner Miami, George Floyd Protests, Oakland City Charter, @OaklandCityCouncil, Oakland 2017 Race and Gender Disparities Study, nfl fall league meeting, NFL on Fox, owners meeting, Vloggercon 2006, josh wolf, International Academy of Web Television, rocketboom, amanda congdon, Carron Phillips Deadspin Jameis Winston, james wiseman warriors, jay blias espn, Mountain View, CA, London, England, Moscow, Russia, Raphael Warnock, Senator Kelly Loeffler, pinewood atlanta, mark dice, White Privilege Tax, Media Analyst, Ronald Jones Bucs, Cal football, UCLA, USC, Stanford, blacks in tech, Tackett Bartlett LLP, Berkeley Bowl, Peets Coffee, @TackettBartlettLLP, Jameis Winston bucs saints florida state, East Bay Regional Park District, Judge John Sutter Regional Shoreline park, Pinewood Studios Atlanta, Jeff Miller, Joceyln Moore, Derek Carr, Marcus Mariota, Regina Jackson, Barry Donelan, Deborah Matthews, Yanqing Ye, UC Berkeley, NFL Owners Meeting, NFL Annual Meeting, Eli Lilly Coronavirus COVID-19 vacine, Summit Bank Oakland, SIFF, Sonoma International Film Festival, Bank of America, Oakland protestors arrested, Juneteenth Rally, Len Raphael, Southern Evangelical Seminary, Richard Land, Kyle Rittenhouse, Jacob Blake, Kenosha, Carroll Fife, Mike Hutchinson Oakland, Alison Roessler, Jane Greenberg, Albert Dicruttalo, Brie Larson, Mayor Of Chicago, Orlando Martinez, Robert F. Smith, supreme court justice ruth bader ginsberg, coalition for police accountability, Youth vs. Apocalypse, Atlanta Mayor Keisha Lance Bottoms, Georgia Governor Brian Kemp, Kate Harrison, Joe Burrow, Cheryl Davila, Mayor Jesse Arreguin, Lori, Droste, Stephanie Walton, Tri Ngo, berkeley marina, berkeley city, Jeff Bezos, Amazon, The Washington Post, Washington Redskins, Washington NFL Football Team, NFL Football Team, Barbara Leslie, Yui Hay Lee, Andreas Cluver, White Journalists, Blacks In Media, Alana Nguyen SFGate, Morgan Bach, Derr & Isbell Construction, Merrill Iron & Steel, Inc WebiMax, Gadook, VJG Interactive, LocalEdge, Digital Firefly Marketing, GreyBox Creative, Igniyte, Reputation Rhino, Netmark, Outspoken Media, SEOValley, WebpageFX, NetReputati, san francisco reputation management, atlanta reputation management, los angeles reputation management, Indeed, airbnb, pinterest, credit karma, Joseph Le Conte, southwest airlines, mcdonalds, united airlines, Peel-A-Pound Soup, drudge report, astros, 49ers, frontier airlines, tractor supply, UC Berkeley ranking, warriors, alaska airlines, buffalo wild wings, horoscope, shein, raiders, uhaul, ted bundy, nba finals, michaels coupon, Tua Tagovailoa, cheesecake factory, golden state warriors, kevin durant, realtor com, stephen curry, walgreens photo, drudge, facebook sign in, funny memes, hbo go, hbo now, oakland raiders, Pacific Merchant Shipping Association, oakland national night out, vistaprint, braves, san francisco 49ers, monday night football, newegg, travis scott, zion williamson, kohls coupons, lands end, nancy pelosi, kohls coupon, hotwire, Kamala Harris, Joe Biden, Patrick Mahomes, mark davis raiders wife, al davis,mark davis net worth, mark davis van, mark davis raiders haircut, mark davis car, mark davis minivan, raiders owner net worth, harry potter, giants, craigslist sf, craig newmark, vic beasley, california earthquake, boston weather, las vegas weather, Eric Metz, sf giants, san francisco weather, san francisco, los angeles weather, lord and taylor, star wars, star wars episode, star trek, star trek discovery, william shatner, ermal allen cowboys, Tom Landry, Jerry Jones, Gil Brandt, Tex Schramm, #Yayarearevolution, zinni.com, zenni.com, leonard nimoy, j.j.abrams, jimmy garoppolo, hawaiian airlines, detective pikachu, clint eastwood, bed bath and beyond coupon, abercrombie, pewdiepie, sfgate, sc lottery, berkeley school, san diego weather, san antonio weather, southwest flights, pikachu, golden state, myatt, just mercy, french open, colourpop, cam newton, anna kendrick, actor, sexual harrassment, klay thompson, harbor freight coupon, robin williams, protest in Oakland, portland protest, Berkeley protest, Chicago protest, LA protest, berkeley university Four Points By Sheraton New York City, Aria Las Vegas, Ballys Las Vegas, Bellagio Las Vegas, Marriott Oakland, Marriott SF, Grand Hyatt San Francisco, Best Western Las Vegas, Caesars Palace, Circus Circus Las Vegas, Cosmopolitan Las Vegas, Beverly Hills Hotel, Beverly Hilton, Delano Las Vegas, Encore Las Vegas, Excalibur Las Vegas, Flamingo Las Vegas, Four Seasons Las Vegas, Harrahs Las Vegas, Linq Las Vegas, Luxor Las Vegas, Mandalay Bay Las Vegas, MGM Grand Las Vegas, Mandarin Oriental, Mirage Las Vegas, Monte Carlo Las Vegas, New York New York Las Vegas, Paris Las Vegas, Palazzo Las Vegas, Planet Hollywood Las Vegas, Stratosphere Las Vegas, Wynn Las Vegas, Venetian Las Vegas, Vdara Las Vegas, Circa Las Vegas, D Hotel Las Vegas Howard Terminal Ballpark, Seattle protest, system dynamics modeling language, air scrubbing and HEPA Filters, Justin Wilcox, David Shaw, Melanie Merkosky, Continuum, CARES Act, Stanford at Cal 123rd Big Game, Bill Musgrave, Justin Wilcox, David Shaw, the informal economy, gross domestic product, LonelyGirl15, Bree, Renetto, vlog life, business finance, portland weather, phoenix weather, Oakland LGBTQ Center, Lakeshore Ave, malcolm miller oakland police cop, rick gates trump interview, small business administration, PPP, north carolina, macbook, how, bath and body works coupon, League of Women Voters of Berkeley, Albany, Emeryville, The Pandemic, community organizer, berkeley coronavirus,, sports events,googleflights, daytona 500, daily horoscope, ashton kutcher, mask, Economic Stimulus, andrew luck, alamo drafthouse, 49ers schedule, trump tweets, MyoKardia, chadwick boseman, colon cancer, Black Panther, MARVEL Entertainment, Disney, thanksgiving,How to, What is, How do I, What do I, Who is? , Electronic Frontier Foundation, Howard Terminal Ballpark, Natalie Silver, Pass It On, Barbara Leslie, Yui Hay Lee, Andreas Cluver, White Journalists, Blacks In Media, David Rubin, Frances Dinkelspiel, Alana Nguyen SFGate, Cat Brooks, Anti Police-Terror Project, Mountain Mike’s Pizza, Glenview, Restorative Justice, School Crossing Guards, berkeley philosophy Bill Belichick ,New England Patriots, Sean Payton, New Orleans Saints, Andy Reid, Kansas City Chiefs , John Harbaugh, Baltimore Ravens, Sean McVay, Los Angeles Rams, Mike Tomlin, Pittsburgh Steelers, Kyle Shanahan, San Francisco 49ers, Pete Carroll, Seattle Seahawks, Bruce Arians, Tampa Bay Buccaneers, Frank Reich, Indianapolis Colts , Mike Zimmer , Minnesota Vikings , Doug Pederson, Philadelphia Eagles , Mike Vrabel, Tennessee Titans , Sean McDermott, Buffalo Bills , Matt Nagy, Chicago Bears , Kliff Kingsbury, Arizona Cardinals , Zac Taylor, Cincinnati Bengals, Bill O’Brien, Houston Texans, Kevin Stefanski, Cleveland Browns, Ron Rivera, Washington Redskins , Brian Flores, Miami Dolphins , Joe Judge, New York Giants, Mike McCarthy, Dallas Cowboys, Matt Rhule, Carolina Panthers, Jon Gruden, Las Vegas Raiders, Matt LaFleur, Green Bay Packers, Anthony Lynn, Los Angeles Chargers, Vic Fangio, Denver Broncos, Dan Quinn, Atlanta Falcons, Matt Patricia, Detroit Lions, Doug Marrone, Jacksonville Jaguars, Adam Gase, New York Jets Also Elon Musk, YouTuber , Ricky Ricardo, Ricky's Sports Theater, Raider Nation, Nura Gabbara, Pat Abraham Yerger, Earline Patricia Yerger, Sunne Wright McPeak, transportation, bullet train, financing debt, Glide Memorial Church SF, Greg McConnell Jobs and Housing Coalition, Oakland Mayor Libby Schaaf @LibbySchaaf, Pamela Price, Councilmember Nikki Fortunato Bas, Dan Kalb of District 1, Loren Taylor, Lynette Gibson McElhaney, Sheng Thao, Noel Gallo, Robert Bobb, Rebecca Kaplan, Larry Reid, Tech Entrepreneur Sarah Lacy, Personal Trainer Megan Avalon Buffed Barbie, Social Media Pioneer Marc Canter, Blake Lindsley, Beth Schnitzer, Spritz Marketing, Eleanor Wikstrom, SF Mayor London Breed, Scott McKibben, CA Assemblymember Buffy Wicks, Schools Superintendent Tony Thurmond, Berkeley Councilmember Ben Bartlett @BenBartlett, Raiders Charles Woodson, 49ers Jerry Rice, Grand Lake Theater Oakland Owner Allan Michaan, Gary Meyer Telluride, Eat Drink Films, C.J. Hirschfeld, Shaun Tai , BRIDGEGOOD, Oakland Digital, Issac Kos-Reed, Salsa-By-The-Lake, AMC Cinemark TinselTown, Children's Fairyland, Irvine City Manager John Russo, Guy Fieri, Oakland CAO Edward Reiskin, Raiders Coach Jon Gruden Running Back Josh Jacobs, Stanford HC David Shaw, Tri Ngo, Atlanta Falcons Coach Dan Quinn, Michael Mina, NFL Draft Mr. Irrelevant Head Melanie Fitch, Paul Satala. Eva Crawford, Lauren Weisheit, Subscribe to Zennie Abraham’s @Zennie62 YouTube Channel, today! ZennieAbraham is Zennie62Media, Inc. CEO AKA Zenophon Abraham Zennie62 YouTube Channel, Zennie62.com, newsbreak.com, nydailynews.com , allhiphop.com, Wonderwall, Eurweb.com, The Source, Oakland CA News, Oakland, California, Oakland vlogger, Oakland News Now Today Blog – SF Bay Area Daily, WordPress user, full stack developer, online reputation management digital marketing expert, SEO, digital media guy, economic development , personal online content , management reputation services, east bay democratic club follower, Oakland Black Panther Elaine Brown, super car stats dude, CES Las Vegas, tech news blog, OaklandNewsOnline.com, OaklandNewsNow.com, OaklandNewsToday.com, Oakland Post, Oaklandpostonline.com, Oakland restaurant foodie fan, Oakland Mayor's Office - Oakland City Council veteran, NBA Blogger, NFL Blogger, Pro Sports Blogger,Super Bowl Bid Expert, Skyline High School Oakland grad, Jeff Katzenberg Quibi App tech commenter, Texas-Arlington Alum, UC Berkeley DCRP Alum, Cal Alumni Board of Directors Alum, Oakland Raiders, The Athletic, Sports Illustrated, Leigh Steinberg, Julia Faron, Chris Cabbot, Cosmo DeNicola, Leigh Steinberg Super Bowl Party, New York 21 Club, Las Vegas Raiders, Dallas Cowboys, NFL, NFL Draft Draftnik, Roger Goodell, Adam Silver NBA, media blogger, social media pioneer, college football news, coder, football strategy junkie, Oakland elections news, zenni, zenni glasses, optical, eyewear, Maria Ayerdi Kaplan, Salesforce Transit Center, Oakland Mayor Libby Schaaf, California Governor Gavin Newsom, Councilmember Noel Gallo, Sheng Thao, Rebecca Kaplan, cheryl davila, Rick Gates Trump, Ben Bartlett Berkeley, Oakland City Attorney Barbara Parker, Treva Reid, Amy Cooper, Chris Cooper, Mary J Blige, jaquar wright, sean puffy combs, Barack Obama, Darrell Williams, Chicago, Murray Energy, International Terminal Solutions, Sanpete County Utah, John Siegel, Autumn Wind Lending, General Partner, Avenue Of The Stars, LLC, Flowsent, Oakland Bulk and Oversized Terminal, OBOT, Las Vegas visitor, Lam Research Corporation, YouTube Partner, friend of Mike Silver, Leslie Silver, Pass It Down podcast, Phil Tagami, Phil Gates, oakland harborside, Nancy Sidebotham, Henry Gardner, Davey D Cook, Ray Bobbitt, Bill Duffy, Robert Bobb, Alan Dones, Loop Capital, Shaun Tai BRIDGEGOOD, Robert G Schock, Barbara Schaaf, Marc Canter, Patricia Yerger Mom, Harrison Chestang, KPOO, Gary Schapiro, Zenophon Abraham Sr. Dad, Vloggerheads.com member, Vloggercon attendee, The Alley Cat Bar regular, Grand Lake Theater marquee fan, United Airlines flier, Walt Disney World lover, System Dynamics consultant, Fluidigm Corporation, Eddie Van Halen, Run DMC, Rolling Stones, Old School Rap fan, Star Trek Trekker, movies buff, San Diego Comic Con Press regular, female bodybuilder fan, Wonder Woman, melissa benoist, Supergirl, Singer Associates, Spritz Marketing SF, Oakland and San Francisco Planning follower, Atlanta Georgia, Atlanta Falcons, Fayette County, Fayetteville observer, Tiger Woods Masters, Tommy Bonk, Robin Carr, Tibor Lacey stop Zenni.com playing with name, Zennie62 YouTube Partner, Hollywood, Oakland California blogger / vlogger hire @Zennie62Media, Inc to tell your story.
;

Oakland News Now Today Blog – SF Bay Area Daily Recent Blog Posts

Do NOT follow this link or you will be banned from the site!